Sanofi
SNY
#175
Rank
โ‚ฌ101.68 B
Marketcap
41,66ย โ‚ฌ
Share price
1.32%
Change (1 day)
-4.69%
Change (1 year)

Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.

Revenue for Sanofi (SNY)

Revenue in 2025 (TTM): โ‚ฌ42.14 Billion

According to Sanofi's latest financial reports the company's current revenue (TTM ) is โ‚ฌ40.49 Billion. In 2024 the company made a revenue of โ‚ฌ42.89 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ46.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sanofi from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ42.14 B-1.75%
2024 โ‚ฌ42.89 B-7.64%
2023 โ‚ฌ46.44 B2.32%
2022 โ‚ฌ45.38 B15.86%
2021 โ‚ฌ39.17 B4.83%
2020 โ‚ฌ37.36 B-0.7%
2019 โ‚ฌ37.63 B5.48%
2018 โ‚ฌ35.67 B-1.48%
2017 โ‚ฌ36.21 B4.33%
2016 โ‚ฌ34.70 B3.63%
2015 โ‚ฌ33.49 B-1.81%
2014 โ‚ฌ34.10 B2.41%
2013 โ‚ฌ33.30 B-7.37%
2012 โ‚ฌ35.95 B2.56%
2011 โ‚ฌ35.05 B9.44%
2010 โ‚ฌ32.03 B4.18%
2009 โ‚ฌ30.74 B6.69%
2008 โ‚ฌ28.81 B-2.37%
2007 โ‚ฌ29.51 B0.05%
2006 โ‚ฌ29.50 B4.18%
2005 โ‚ฌ28.32 B85.8%
2004 โ‚ฌ15.24 B88.61%
2003 โ‚ฌ8.08 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
โ‚ฌ54.72 B 35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.49 B 32.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.92 B 1.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.02 B 18.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
โ‚ฌ36.08 B-10.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.29 B-64.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ78.51 B 93.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.62 B 25.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ40.22 B-0.66%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Abbott Laboratories
ABT
โ‚ฌ37.35 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA